{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T17:37:55Z","timestamp":1784828275059,"version":"3.55.0"},"reference-count":46,"publisher":"Norwegian Medical Association","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2012,8,7]]},"DOI":"10.4045\/tidsskr.11.1518","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T07:27:48Z","timestamp":1344497268000},"page":"1610-3","source":"Crossref","is-referenced-by-count":4,"title":["Juvenil myoklonusepilepsi"],"prefix":"10.4045","volume":"132","author":[{"given":"Marte Roa","family":"Syvertsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Markhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja Kristine","family":"Selmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1851-4857","authenticated-orcid":false,"given":"Karl O.","family":"Nakken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005; 46 (suppl 9): 10\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16302871&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2005.00309.x","DOI":"10.1111\/j.1528-1167.2005.00309.x"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Eadie MJ. The epileptology of Th\u00e9odore Herpin (1799\u2009\u2013\u20091865). Epilepsia 2002; 43: 1256\u2009\u2013\u200961. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12366743&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1046\/j.1528-1157.2002.04602.x","DOI":"10.1046\/j.1528-1157.2002.04602.x"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Janz D, Christian W. Impulsiv petit mal. Dtsch Z Nervenheilkd 1957; 176: 346\u2009\u2013\u200986. Crossref: http:\/\/dx.doi.org\/10.1007\/BF00242439","DOI":"10.1007\/BF00242439"},{"key":"ref=4","unstructured":"Lund M, Reintoft H, Simonsen N. En kontrolleret social og psychologisk undersogelse af patienten med juvenil myoclon epilepsi. Ugeskr L\u00e6ger 1975; 137: 2415\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=809883&dopt=Abstract"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Asconap\u00e9 J, Penry JK. Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia 1984; 25: 108\u2009\u2013\u200914. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6420145&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1984.tb04163.x","DOI":"10.1111\/j.1528-1157.1984.tb04163.x"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Delgado-Escueta AV, Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984; 34: 285\u2009\u2013\u200994. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6422321&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212\/WNL.34.3.285","DOI":"10.1212\/WNL.34.3.285"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389\u2009\u2013\u200999. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2502382&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1989.tb05316.x","DOI":"10.1111\/j.1528-1157.1989.tb05316.x"},{"key":"ref=8","unstructured":"Thomas P, Genton P, Gelisse P et al. Juvenile myoclonic epilepsy. I: Roger J, Bureau M, Dravet C et\u00a0al, red. Epileptic syndromes in Infancy, Childhood and Adolescence. 3. opplag. Montrouge: John Libbey Eurotext, 2002; 335\u2009\u2013\u200956."},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Pal DK, Pong AW, Chung WK. Genetic evaluation and counseling for epilepsy. Nat Rev Neurol 2010; 6: 445\u2009\u2013\u200953. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20647993&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/nrneurol.2010.92","DOI":"10.1038\/nrneurol.2010.92"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Greenberg DA, Durner M, Keddache M et al. Reproducibility and complications in gene searches: linkage on chromosome 6, heterogeneity, association, and maternal inheritance in juvenile myoclonic epilepsy. Am J Hum Genet 2000; 66: 508\u2009\u2013\u200916. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10677311&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086\/302763","DOI":"10.1086\/302763"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Pal DK, Evgrafov OV, Tabares P et al. BRD2 (RING3) is a probable major susceptibility gene for common juvenile myoclonic epilepsy. Am J Hum Genet 2003; 73: 261\u2009\u2013\u200970. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12830434&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086\/377006","DOI":"10.1086\/377006"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Helbig I, Mefford HC, Sharp AJ et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009; 41: 160\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19136953&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/ng.292","DOI":"10.1038\/ng.292"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Cossette P, Liu L, Brisebois K et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 2002; 31: 184\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11992121&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/ng885","DOI":"10.1038\/ng885"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Suzuki T, Delgado-Escueta AV, Aguan K et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 2004; 36: 842\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15258581&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/ng1393","DOI":"10.1038\/ng1393"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Moschetta S, Fiore LA, Fuentes D et al. Personality traits in patients with juvenile myoclonic epilepsy. Epilepsy Behav 2011; 21: 473\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21683658&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.yebeh.2011.03.036","DOI":"10.1016\/j.yebeh.2011.03.036"},{"key":"ref=16","unstructured":"Devinsky O, Gershengorn J, Brown E et al. Frontal functions in juvenile myoclonic epilepsy. Neuropsychiatry Neuropsychol Behav Neurol 1997; 10:\u00a0243\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9359121&dopt=Abstract"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Tae WS, Kim SH, Joo EY et al. Cortical thickness abnormality in juvenile myoclonic epilepsy. J Neurol 2008; 255: 561\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18227991&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00415-008-0745-6","DOI":"10.1007\/s00415-008-0745-6"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"de Ara\u00fajo Filho GM, Jackowski AP, Lin K et al. Personality traits related to juvenile myoclonic epilepsy: MRI reveals prefrontal abnormalities through a voxel-based morphometry study. Epilepsy Behav 2009; 15: 202\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19303459&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.yebeh.2009.03.011","DOI":"10.1016\/j.yebeh.2009.03.011"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Meencke HJ, Janz D. Neuropathological findings in primary generalized epilepsy: a study of eight cases. Epilepsia 1984; 25: 8\u2009\u2013\u200921. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=6692795&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1984.tb04149.x","DOI":"10.1111\/j.1528-1157.1984.tb04149.x"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Janz D. Juvenile myoclonic epilepsy. Epilepsy with impulsive petit mal. Cleve Clin J Med 1989; 56 (suppl Pt 1): S23\u2009\u2013\u200933, discussion S40\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2498010&dopt=Abstract","DOI":"10.3949\/ccjm.56.s1.23"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Canevini MP, Mai R, Di Marco C et al. Juvenile myoclonic epilepsy of Janz: clinical observations in\u00a060 patients. Seizure 1992; 1: 291\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1344779&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/1059-1311(92)90039-4","DOI":"10.1016\/1059-1311(92)90039-4"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy: a 5-year prospective study. Epilepsia 1994; 35: 285\u2009\u2013\u200996. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8156946&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1994.tb02432.x","DOI":"10.1111\/j.1528-1157.1994.tb02432.x"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Cvetkovska E, Panov S. Possible genetic anticipation in families with idiopathic generalised epilepsy. Epileptic Disord 2011; 13: 150\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21636347&dopt=Abstract","DOI":"10.1684\/epd.2011.0441"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Wirrell EC, Camfield CS, Camfield PR et al. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996; 47: 912\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8857718&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212\/WNL.47.4.912","DOI":"10.1212\/WNL.47.4.912"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998; 7: 31\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9548223&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1059-1311(98)90005-X","DOI":"10.1016\/S1059-1311(98)90005-X"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Dhanuka AK, Jain BK, Daljit S et al. Juvenile myoclonic epilepsy: a clinical and sleep EEG study. Seizure 2001; 10: 374\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11488650&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1053\/seiz.2001.0522","DOI":"10.1053\/seiz.2001.0522"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Pedersen SB, Petersen KA. Juvenile myoclonic epilepsy: clinical and EEG features. Acta Neurol Scand 1998; 97: 160\u2009\u2013\u20093. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9531431&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.1998.tb00630.x","DOI":"10.1111\/j.1600-0404.1998.tb00630.x"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Atakli D, S\u00f6z\u00fcer D, Atay T et al. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998; 7: 63\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9548228&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1059-1311(98)90010-3","DOI":"10.1016\/S1059-1311(98)90010-3"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Vijai J, Cherian PJ, Stlaja PN et al. Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands. Seizure 2003; 12: 490\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12967578&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1059-1311(03)00049-9","DOI":"10.1016\/S1059-1311(03)00049-9"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Satishchandra P, Sinha S. Progressive myoclonic epilepsy. Neurol India 2010; 58: 514\u2009\u2013\u200922. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20739785&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4103\/0028-3886.68660","DOI":"10.4103\/0028-3886.68660"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1016\u2009\u2013\u200926. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17382828&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0140-6736(07)60461-9","DOI":"10.1016\/S0140-6736(07)60461-9"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Calleja S, Salas-Puig J, Ribacoba R et al. Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. Seizure 2001; 10: 424\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11700996&dopt=Abstract","DOI":"10.1053\/seiz.2000.0530"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10660394&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJM200002033420503","DOI":"10.1056\/NEJM200002033420503"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Tomson T, Battino D, Bonizzoni E et al. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurol 2011; 10: 609\u2009\u2013\u200917. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21652013&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S1474-4422(11)70107-7","DOI":"10.1016\/S1474-4422(11)70107-7"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Isoj\u00e4rvi J. Disorders of reproduction in patients with epilepsy: antiepileptic drug related mechanisms. Seizure 2008; 17: 111\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18164216&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.seizure.2007.11.007","DOI":"10.1016\/j.seizure.2007.11.007"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Bodenstein-Sachar H, Gandelman-Marton R, Ben-Zeev B et al. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy. Acta Neurol Scand 2011; 124: 22\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21208196&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2010.01472.x","DOI":"10.1111\/j.1600-0404.2010.01472.x"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Rosenfeld WE, Benbadis S, Edrich P et al. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies. Epilepsy Res 2009; 85: 72\u2009\u2013\u200980. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19327967&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.eplepsyres.2009.02.016","DOI":"10.1016\/j.eplepsyres.2009.02.016"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Aurlien D, Taub\u00f8ll E, Gjerstad L. Lamotrigine in idiopathic epilepsy \u2013 increased risk of cardiac death? Acta Neurol Scand 2007; 115: 199\u2009\u2013\u2009203. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17295716&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2006.00730.x","DOI":"10.1111\/j.1600-0404.2006.00730.x"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Hesdorffer DC, Tomson T, Benn E et al. Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis. Epilepsia 2012; 53: 249\u2009\u2013\u200952. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22191685&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1167.2011.03354.x","DOI":"10.1111\/j.1528-1167.2011.03354.x"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Mantoan L, Walker M. Treatment options in juvenile myoclonic epilepsy. Curr Treat Options Neurol 2011; 13: 355\u2009\u2013\u200970. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21494841&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s11940-011-0131-z","DOI":"10.1007\/s11940-011-0131-z"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Obeid T, Panayiotopoulos CP. Clonazepam in juvenile myoclonic epilepsy. Epilepsia 1989; 30: 603\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2507306&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1989.tb05479.x","DOI":"10.1111\/j.1528-1157.1989.tb05479.x"},{"key":"ref=42","doi-asserted-by":"crossref","unstructured":"Lerman P, Nussbaum E. The use of sulthiame- in myoclonic epilepsy of childhood and adolescence. Acta Neurol Scand Suppl 1975; 60: 7\u2009\u2013\u200912. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=242184&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.1975.tb01382.x","DOI":"10.1111\/j.1600-0404.1975.tb01382.x"},{"key":"ref=43","doi-asserted-by":"crossref","unstructured":"Perucca E, Gram L, Avanzini G et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 1998; 39: 5\u2009\u2013\u200917. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9578007&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1998.tb01268.x","DOI":"10.1111\/j.1528-1157.1998.tb01268.x"},{"key":"ref=44","doi-asserted-by":"crossref","unstructured":"Gelisse P, Genton P, Thomas P et al. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 240\u2009\u2013\u20093. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11160477&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.70.2.240","DOI":"10.1136\/jnnp.70.2.240"},{"key":"ref=45","doi-asserted-by":"crossref","unstructured":"Shorvon S. Risk factors for sudden unexpected death in epilepsy. Epilepsia 1997; 38 (suppl): S20\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19909317&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1528-1157.1997.tb06118.x","DOI":"10.1111\/j.1528-1157.1997.tb06118.x"},{"key":"ref=46","doi-asserted-by":"crossref","unstructured":"Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology 2009; 73: 1041\u2009\u2013\u20095. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19786695&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212\/WNL.0b013e3181b9c86f","DOI":"10.1212\/WNL.0b013e3181b9c86f"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:28:08Z","timestamp":1781656088000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/08\/oversiktsartikkel\/juvenil-myoklonusepilepsi"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,7]]},"references-count":46,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2012,8,7]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.11.1518","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,7]]}}}